194 related articles for article (PubMed ID: 17579883)
1. Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.
Hedmer M; Höglund P; Cavallin-Ståhl E; Albin M; Jönsson BA
Int Arch Occup Environ Health; 2008 Jan; 81(3):285-93. PubMed ID: 17579883
[TBL] [Abstract][Full Text] [Related]
2. Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism.
Busse D; Busch FW; Bohnenstengel F; Eichelbaum M; Fischer P; Opalinska J; Schumacher K; Schweizer E; Kroemer HK
J Clin Oncol; 1997 May; 15(5):1885-96. PubMed ID: 9164199
[TBL] [Abstract][Full Text] [Related]
3. Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolism.
Busse D; Busch FW; Schweizer E; Bohnenstengel F; Eichelbaum M; Fischer P; Schumacher K; Aulitzky WE; Kroemer HK
Cancer Chemother Pharmacol; 1999; 43(3):263-8. PubMed ID: 9923558
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.
Anderson LW; Chen TL; Colvin OM; Grochow LB; Collins JM; Kennedy MJ; Strong JM
Clin Cancer Res; 1996 Sep; 2(9):1481-7. PubMed ID: 9816324
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopy.
Joqueviel C; Martino R; Gilard V; Malet-Martino M; Canal P; Niemeyer U
Drug Metab Dispos; 1998 May; 26(5):418-28. PubMed ID: 9571223
[TBL] [Abstract][Full Text] [Related]
6. Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry.
Sottani C; Turci R; Perbellini L; Minoia C
Rapid Commun Mass Spectrom; 1998; 12(16):1063-8. PubMed ID: 9737012
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
de Jonge ME; van Dam SM; Hillebrand MJ; Rosing H; Huitema AD; Rodenhuis S; Beijnen JH
J Mass Spectrom; 2004 Mar; 39(3):262-71. PubMed ID: 15039933
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients.
Al-Rawithi S; El-Yazigi A; Ernst P; Al-Fiar F; Nicholls PJ
Bone Marrow Transplant; 1998 Sep; 22(5):485-90. PubMed ID: 9733272
[TBL] [Abstract][Full Text] [Related]
9. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of (R)- and (S)-cyclophosphamide and their dechloroethylated metabolites in cancer patients.
Williams ML; Wainer IW; Granvil CP; Gehrcke B; Bernstein ML; Ducharme MP
Chirality; 1999; 11(4):301-8. PubMed ID: 10224657
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
Hon CY; Teschke K; Shen H; Demers PA; Venners S
Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912
[TBL] [Abstract][Full Text] [Related]
12. Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide.
Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Draicchio F; Apostoli P
Rapid Commun Mass Spectrom; 1998; 12(20):1485-93. PubMed ID: 9796535
[TBL] [Abstract][Full Text] [Related]
13. A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.
Hassan M; Svensson US; Ljungman P; Björkstrand B; Olsson H; Bielenstein M; Abdel-Rehim M; Nilsson C; Johansson M; Karlsson MO
Br J Clin Pharmacol; 1999 Nov; 48(5):669-77. PubMed ID: 10594468
[TBL] [Abstract][Full Text] [Related]
14. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of cyclophosphamide in the urine of antineoplastic drugs handlers].
Favier B; Gilles L; Desage M; Latour JF
Bull Cancer; 2003 Oct; 90(10):905-9. PubMed ID: 14706919
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 5-fluorouracil and cyclophosphamide in depression rats.
Duan JJ; Zhou T; Chen X; Wang Y; Wen YG; Xu F
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):427-36. PubMed ID: 22696869
[TBL] [Abstract][Full Text] [Related]
17. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
Chen TL; Kennedy MJ; Anderson LW; Kiraly SB; Black KC; Colvin OM; Grochow LB
Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of occupational exposure to cyclophosphamide in nine hospitals of Peru].
Rosales-Rimache JA
Rev Peru Med Exp Salud Publica; 2013; 30(4):590-4. PubMed ID: 24448934
[TBL] [Abstract][Full Text] [Related]
19. [The determination of urinary cyclophosphamide at low concentration levels by liquid-liquid extraction and HPLC/MS/MS analysis].
Sottani C; Turci R; Perbellini L; Minoia C
G Ital Med Lav Ergon; 1998; 20(4):239-42. PubMed ID: 9987616
[TBL] [Abstract][Full Text] [Related]
20. The influence of interferon-alpha on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite in patients with multiple myeloma.
Hassan M; Nilsson C; Olsson H; Lundin J; Osterborg A
Eur J Haematol; 1999 Sep; 63(3):163-70. PubMed ID: 10485271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
